Wyeth-Ayerst/Aviron Flumist
Executive Summary
Vaccines & Related Biological Products Advisory Committee will meet to discuss nasal influenza vaccine Flumist on July 26-27. The committee will discuss Flumist's safety and efficacy data on the first day of the meeting and the product's proposed indications on the second day. The meeting begins at 10:15 a.m. on July 26 and at 8:30 a.m. on July 27 and will be held at the Holiday Inn in Gaithersburg, Md. Wyeth told investors in April it expected the committee to review the product in July (1"The Pink Sheet" April 30, In Brief)